Navigation Links
UCSF receives $112 million to help translate science into cures
Date:7/18/2011

A UCSF institute aimed at accelerating the pace of translating science into real-life solutions for patients has received $112 million from the National Institutes of Health to expand its work over the next five years.

The UCSF Clinical and Translational Science Institute (CTSI) is among 10 institutes nationwide to receive the renewed funding, in recognition of their successes during the first five years of the NIH's Clinical and Translational Science Awards program.

Together, the institutes represent a $498 million renewed commitment on NIH's part to expedite translational research nationwide. UCSF received the largest of the renewal grants and remains the country's second-largest clinical and translational science institute.

The other institutions include Columbia University Medical Center, Mayo Clinic, Oregon Health & Sciences University, Rockefeller University, UC Davis, University of Pennsylvania, University of Pittsburgh, University of Rochester, and Yale University.

"These institutes were the pioneers in this program and are to be commended for the work they have done in bridging the traditional divides between laboratory research and medical practice," said Barbara Alving, MD, director of the NIH's National Center for Research Resources, which administers the CTSA program. "They were tasked with transforming the way their institutions coordinate research to make it more proactive and effective in producing real-world results, and in the process, they have served as innovative models nationwide."

NIH will release a progress report on the program in August, highlighting research that has emerged from UCSF and other institutes in the CTSA consortium.

Promoting Collaboration

The renewal awards validate the success of CTSI and its sister programs in creating a framework for scientists to move beyond the traditional silos of science to collaborate on promising research and find the training and resources to move those projects ahead.

The UCSF institute has focused on creating resources at all levels of that spectrum, from fundamental biological research to industry partnerships, clinical trials and clinical research. The renewed funding will expand and enhance those programs, while also supporting CTSI's efforts to take those advances one step further to ensure they reach the community.

"UCSF is known for both outstanding fundamental research and for the level of care it provides to patients who are in greatest need," said UCSF Chancellor Susan Desmond-Hellmann, MD, MPH. "CTSI is helping us create that 'secret sauce' to help connect these two communities and deliver the breakthroughs that patients need throughout the world."

The size of UCSF's renewal underscores its leadership role across the 60 institutes that have been created through the NIH program, as well as the value of CTSI projects that will be rolled out under the new funding.

Bridging the Gap

CTSI was among the first seven of these institutes nationwide and was the largest when it received its initial 2006 grant award, totaling more than $100 million. Since then, the institute has enabled UCSF to create an extensive network of training and support for researchers to help bridge the gaps between laboratory science, clinical care, and improvements in health.

"UCSF is an incredible place, with superb basic science and also groundbreaking clinical research and care," said UCSF neurologist and CTSI Director S. Claiborne "Clay" Johnston, MD, PhD. "The great collaborative spirit of UCSF has made bridging the gap between these two types of research very doable. It has been exciting to think through how we might best facilitate our great faculty and to see some early evidence of success."

Research acceleration happens in a variety of ways, including identifying and addressing challenges that affect successful clinical research, such as the failure to recruit study participants. In response CTSI developed the UCSF Participant Recruitment Service, which will begin a pilot program later this summer.

"One of the greatest challenges clinical investigators face is finding enough people to enroll in studies," said Bill Balke, MD, director of CTSI's Clinical Research Services. "This program, the first of its kind at UCSF, will give researchers the tools and support they need to find and enroll study participants."

Breaking down Obstacles

Another key obstacle is funding. CTSI has awarded $4.5 million in pilot awards over the past four years, distributed across UCSF's four professional schools Dentistry, Medicine, Nursing and Pharmacy and will continue to support early-stage, or T1, research through a newly launched program, known as the T1 Translational Catalyst Award. That program helps researchers understand where their research stands in terms of commercial viability and pairs them with teams of academic and industry consultants to resolve critical obstacles early in the research process.

The institute also has created a comprehensive Consultation Service, the busiest of its kind across the national consortium, which matches researchers to faculty who help them address study design, complex biostatistics and a range of specialized research needs.

Beyond expert advice and funds, CTSI's Clinical Research Services has helped advance clinical research at UCSF by providing integrated services at eight adult and pediatric sites across the San Francisco Bay Area, ranging from nursing staff to sample processing and participant recruitment. The service has supported more than 1,500 UCSF and affiliated doctors in applying research advances to clinical practice.

Among the future projects are opportunities for UCSF scientists to collaborate with UC Berkeley to capitalize on its complementary strengths in engineering and business. CTSI is also launching strategic initiatives, such as a program that leverages community partnerships and research at UCSF to achieve measurable improvements in health for the San Francisco Bay Area.

Over the next five years, the UCSF institute will capture and relay key statistics on return on investment (ROI) and other metrics of success to expand not only its programs, but its ability to share progress rigorously and transparently. The institute will also share the software and other programs it has developed with the national network of institutes.


'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
2. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
3. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
4. BestMassage.com Receives Award for Customer Trust
5. Corporate Wellness Firm Limeade Receives SAS 70 Type II Report
6. Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award
7. Special Olympics Georgia Receives Grant from The Home Depot Foundation
8. NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter
9. WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility
10. Verdan Receives Patent on Crystal Deodorant Spray
11. Thomas E. Mower Meets With Dalai Lama; Receives Prestigious Champion Award from Whole Child International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
Breaking Medicine Technology: